What is Galvanize Theraputics?
Headquartered in Redwood City, California, Galvanize Theraputics is a medical technology innovator dedicated to advancing biologic processes through its revolutionary Aliya PEF energy platform. The company occupies a critical niche in the life sciences sector, focusing on the development and commercialization of energy-based therapies designed to address complex medical challenges, including solid tumors and chronic bronchitis. By leveraging pulsed electric field technology, Galvanize Theraputics aims to establish a new standard of care, positioning itself as a leader in the intersection of advanced engineering and clinical medicine.
How much funding has Galvanize Theraputics raised?
Galvanize Theraputics has raised a total of $196.1M across 2 funding rounds:
Series C
$100M
Private Equity
$96.1M
Series C (2025): $100M with participation from Intuitive Surgical, Ally Bridge Group, Gilmartin Capital, T. Rowe Price, Fidelity, Longaeva Books, Sofinnova Partners, Apple Tree Partners, Janus Henderson Investors, Norwest Venture Partners, and Elevage Medical Technologies
Private Equity (2025): $96.1M, investors not publicly disclosed
Key Investors in Galvanize Theraputics
Ally Bridge Group
Ally Bridge Group is a global healthcare investment management firm that specializes in high-impact life science innovation, managing over $6 billion in transactions since its inception in 2013.
Gilmartin Capital
Gilmartin Capital invests in entrepreneurs focused on platforms that address large or underserved diseases, technologies that enhance scientific discovery, and solutions that improve the cost and delivery of care.
Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability, acting as a hands-on company builder across the entire value chain.
What's next for Galvanize Theraputics?
With this major enterprise-level funding, Galvanize Theraputics is well-positioned to accelerate its clinical development programs and expand the commercial footprint of the Aliya PEF platform within the United States. The strategic backing from a consortium of specialized healthcare investors provides the necessary resources to scale operations, refine its therapeutic pipeline, and navigate the regulatory landscape for broader market adoption. Future growth will likely center on expanding the clinical indications for its energy-based solutions, thereby solidifying its market position as a transformative force in medical device innovation.
See full Galvanize Theraputics company page
